A clinical staging classification for type C Niemann-Pick disease

Neurology. 1992 Dec;42(12):2286-90. doi: 10.1212/wnl.42.12.2286.

Abstract

Analysis of the temporal sequence of neurologic events, neurophysiologic abnormalities, and longevity in 36 Niemann-Pick type C patients revealed two clinical subgroups with five stages of severity within each group. Patients with a preschool onset (group I; n = 18) had a higher mortality than did patients with a school-age onset (group II; n = 18). An asymptomatic phase (stage 0) was defined by biochemical and histopathologic evidence of disease. The initial manifestations of stage 1 were a movement disorder (group I) and cognitive difficulties (group II) accompanied by impaired vertical saccadic eye movements and abnormal acoustic reflexes. Stage 2 was characterized by the sequential occurrence of vertical supranuclear gaze palsy (VSGP), cognitive difficulties, and dysarthria in group I and a movement disorder, VSGP, and dysarthria in group II. Pyramidal tract signs and abnormal brainstem auditory evoked responses defined stage 3 in both groups. Stage 4 culminated in a nonambulant, vegetative state.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Cholesterol Esters / metabolism
  • Electroencephalography
  • Evoked Potentials / physiology
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Niemann-Pick Diseases / classification*
  • Niemann-Pick Diseases / mortality
  • Niemann-Pick Diseases / physiopathology
  • Risk Factors
  • Survival Analysis

Substances

  • Cholesterol Esters